Modified pustulotic arthro-osteitis diagnostic guidance 2022 – Modified Sonozaki criteria – Secondary publication

Author:

Tsuji Shigeyoshi1ORCID,Okubo Yukari2,Kishimoto Mitsumasa3,Taniguchi Yoshinori4,Ishihara Yoko5,Tamura Masao6,Kobayashi Satomi5,Watanabe Rei78,Takakubo Yuya9,Tomita Tetsuya10

Affiliation:

1. Department of Rehabilitation, Orthopaedic Surgery, Psoriasis Center, Nippon Life Hospital , Osaka, Japan

2. Department of Dermatology, Tokyo Medical University , Tokyo, Japan

3. Department of Nephrology and Rheumatology, Kyorin University School of Medicine , Mitaka, Tokyo, Japan

4. Department of Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School Hospital, Kochi University , Nankoku, Kochi, Japan

5. Department of Dermatology, Seibo International Catholic Hospital , Tokyo, Japan

6. Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University , Nishinomiya, Japan

7. Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University , Osaka, Japan

8. Department of Integrative Medicine for Allergic and Immunological Diseases, Course of Integrated Medicine, Graduate School of Medicine, Osaka University , Osaka, Japan

9. Department of Orthopaedic Surgery & Rehabilitation, Yamagata University Faculty of Medicine , Yamagata, Japan

10. Graduate School of Health Science, Morinomiya University of Medical Sciences , Osaka, Japan

Abstract

ABSTRACT The concept of pustulotic arthro-osteitis (PAO) was first reported by Sonozaki et al. in 1979, with diagnostic criteria (Sonozaki criteria) proposed in 1981. These criteria have served as the gold standard for PAO diagnosis for over 40 years. In recent years, there has been an increasing emphasis on maximizing the quality of life of patients with PAO. This is achieved by striving for clinical remission, structural remission, and functional remission through early diagnosis and appropriate therapeutic intervention from an early stage. This article is an English translation of a summary of the ‘Modified PAO Diagnostic Guidance 2022ʹ, edited by the Japan Ministry of Health, Labour and Welfare’s Research Group on improvement of medical standard and quality of life of patients with spondyloarthritis and related diseases represented by ankylosing spondylitis and the Japan Spondyloarthritis Society. This guidance is intended to be helpful to both Japanese and global communities in rheumatology and spondyloarthritis.

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3